Discuss all risks and benefits with your doctor, especially if you are pregnant, breastfeeding, or have a history of heart, kidney, or electrolyte disorders
Mouse metabolism, mouse fat biology, and mouse dosing all differ from the human versions, and metabolic findings in rodents have a long history of not carrying over cleanly to people
That single block sets off a chain of changes inside fat cells
We cant apply the findings to humans due to different metabolism and physiology
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
Your provider at Auri Aesthetics can discuss options during your visit